Allon Therapeutics allontherapeutics.com


Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on developing the first drugs that impact the progression of neurodegernative diseases. Therapies available today treat only symptoms and have no effect on the course of the diseases.

Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on developing the first drugs that impact the progression of neurodegernative diseases. Therapies available today treat only symptoms and have no effect on the course of the d...Show all

Company (Acquired)

Phone:

Fax:

San Diego, 92101
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Allon Therapeutics $2.5M Sep 10, 2004
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Allon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show allLogin to see details

Celera Genomics

Rockville, Maryland, United States
Alive / ActiveCelera Genomics is one of three business segments of Applera Corporation. Celera Genomic's mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medicinal chemistry and biology technology platforms to identify and validate drug targets, and to discover novel therapeutics. Celera Genomics currently has a portfolio of programs based primarily on protease inhibitors for three major therapeutic areas: ...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Neuroprotection using nap-like and sal-like peptide mimetics Feb 18, 2010 Dec 04, 2012 Patent
Use of adnf polypeptides for treating peripheral neurotoxicity Oct 03, 2008 Mar 27, 2012 Patent